Gabe Scannapieco to Speak on CSA Liability at 7th Annual Summit on Controlled Substances – Regulation, Litigation, and Enforcement

Event Details

On January 27, 2026, AGG Healthcare partner and Life Sciences industry team co-chair, Gabe Scannapieco, will lead a session titled “Targeting Online Diversion: CSA Liability for Algorithmic Tools and Marketplace Design” at the 7^th Annual Summit on Controlled Substances – Regulation, Litigation, and Enforcement in New York, New York.

Gabe will discuss the latest enforcement risks under the Controlled Substances Act (“CSA”); audit and remediation strategies for algorithmic tools; and how to build a defensible, compliance-first operational approach. The session will address high-risk features like content ranking and search optimization, recent regulatory actions against digital intermediaries, and practical steps for platform operators and third-party vendors.

To register, please click here.